|
2023
|
Invention
|
Solid forms of a compound for treating or preventing hyperuricemia or gout. Crystalline forms of ... |
|
|
Invention
|
Compound capable of being used for gout. Disclosed is a compound capable of being used for gout. ... |
|
|
Invention
|
Compound for reducing uric acid. Disclosed herein is a compound for reducing uric acid, which is ... |
|
2022
|
Invention
|
Anti-inflammatory and analgesic compounds and use thereof. The present invention belongs to the f... |
|
|
Invention
|
Anti-inflammatory analgesic compound and use thereof. The present invention belongs to the field ... |
|
|
Invention
|
Xanthine oxidase inhibitor.
It discloses a compound shown in general formula (1) or a pharmaceut... |
|
|
Invention
|
A xanthine oxidase inhibitor. The present invention relates to a class of xanthine oxidase inhibi... |
|
|
Invention
|
Class of xanthine oxidase inhibitors. The present invention relates to a class of xanthine oxidas... |
|
2020
|
Invention
|
Compound having therapeutic efficacy for liver disease. A compound having therapeutic efficacy fo... |
|
|
Invention
|
Synthesis for 3-bromo-5-(2-ethylimidazo[1, 2-alpha]pyridine- 3-carbonyl)-2-hydroxybenzonitrile.
... |
|
|
Invention
|
Synthesis of 3-bromo-5-(2-ethylimidazo[1,2-α]pyridine-3-carbonyl)-2-hydroxybenzonitrile. Disclose... |
|
2019
|
Invention
|
Use of 4-(benzothiazole-2-yl)arylamine compound in treating stomach cancer. Disclosed is the use ... |
|
|
Invention
|
Use of 4-(benzselenazol-2-yl)arylamine compound in treating stomach cancer or intestinal cancer. ... |
|
|
Invention
|
Pharmaceutical compounds for treating liver diseases and application thereof. Disclosed are a cla... |
|
|
Invention
|
Compound for treatment or prevention of liver diseases. The invention discloses compounds for tre... |
|
|
Invention
|
Compounds for treatment or prevention of liver diseases. Disclosed are compounds for the treatmen... |
|
|
Invention
|
Compound for treatment or prevention of liver diseases. Disclosed are compounds for the treatment... |
|
|
Invention
|
Urat1 inhibitor and use thereof. Disclosed are a class of URAT1 inhibitor compounds and the use o... |
|
2018
|
Invention
|
Urat1 inhibitor for promoting uric acid excretion. The present invention belongs to the field of ... |
|
|
Invention
|
Urat1 inhibitor for increasing uric acid excretion. The present invention belongs to the field of... |
|
2017
|
Invention
|
Urat1 inhibitors and applications thereof. Disclosed are a class of URAT1 inhibitor compounds and... |
|
|
Invention
|
Novel urat1 inhibitor and pharmaceutical application thereof. A novel URAT1 inhibitor and a pharm... |
|
2016
|
Invention
|
Compound for treating or preventing hyperuricemia or gout. The invention discloses a class of com... |
|
|
Invention
|
A group of compounds used for the treatment or prevention of hyperuricemia or gout. Abstract of t... |
|
|
Invention
|
Compound for treating or preventing hyperuricemia or gout. Provided are a compound as represented... |
|
|
Invention
|
Compounds for the treatment or prevention of breast cancer. It discloses compounds for the treatm... |
|
|
Invention
|
Compound for treating or preventing breast cancer. Disclosed are a class of compounds for treatin... |
|
2013
|
Invention
|
2-aryl selenazole compound and pharmaceutical composition thereof. A 2-aryl selenazole compound a... |
